Show pageBacklinksCite current pageExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. The VHL gene provides instructions for making a [[protein]] that functions as part of a complex (a group of proteins that work together) called the VCB-CUL2 complex. This complex targets other proteins to be broken down (degraded) by the cell when they are no longer needed. [[Hemangioblastoma]]s may arise sporadically in a solitary form or associated with [[Von Hippel-Lindau disease]] with multiple tumors. [[VHL protein]] is defective in both forms of [[hemangioblastoma]], leading to the accumulation of hypoxia-inducible factor, stimulating [[angiogenesis]] via [[VEGF]] and [[PDGF]] mainly ((Migliorini D, Haller S, Merkler D, Pugliesi-Rinaldi A, Koka A, Schaller K, Leemann B, Dietrich PY. Recurrent multiple CNS hemangioblastomas with VHL disease treated with pazopanib: a case report and literature review. CNS Oncol. 2015;4(6):387-92. doi: 10.2217/cns.15.22. Epub 2015 Oct 26. PMID: 26497655; PMCID: PMC6083944.)). vhl_protein.txt Last modified: 2024/06/07 02:50by 127.0.0.1